Product
Name :
Flixonase Nasal Spray
Other
Brand Names :
Flonase - United
States and Canada, Flixonase - Europe
Product
Type :
Steroidal
Anti-inflammatory Agent (Nasal) - Fluticasone Propionate
Manufacturer :
Allen and Hanburys -
Glaxo Wellcome
Packaging
and Product :
Nasal Spray containing
120 doses
Product
Classification :
Pharmacist Only
Medicine
Nasal fluticasone propionate
belongs to a class of anti-inflammatory agents called
corticosteroids. It is used to treat rhinitis or inflammation of
the nasal mucus membranes. It works by inhibiting the production
of allergic and inflammatory mediators in the body.
INDICATIONS
Prevention and treatment of seasonal
allergic rhinitis including hay fever, and perennial rhinitis.
When used topically on the nasal mucosa Flixonase has no
detectable systemic activity.
CONTRA-INDICATIONS
Allergy to any of the ingredients.
WARNINGS AND PRECAUTIONS
Infections of the nasal airways should
be appropriately treated but do not constitute a specific
contra-indication to treatment. The full benefit may not be
achieved for several days. An abnormally heavy challenge of
summer allergens may in certain instances necessitate
appropriate additional therapy, particularly to control eye
symptoms.
Care while transferring patients from
systemic steroid treatment if there is any reason to suppose
that their adrenal function is impaired. Recurrent epistaxis or
recent nasal septum surgery.
PREGNANCY AND LACTATION
The benefits must be weighed against the
possible risks associated with the product or with any
alternative therapy.
ADVERSE
EFFECTS
Dryness and irritation of the nose and
throat, unpleasant taste and smell, nose bleeds and allergic
reactions including skin rash, swelling of the face or tongue
and, rarely, bronchospasm have been reported. Extremely rare
cases of nasal septal perforation.
OVERDOSAGE
There is no data available on the
effects of acute or chronic overdosage with FLIXONASE Aqueous
Nasal Spray. |
